Federal (United States) · Regulations
Subpart C — Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
26 sections
26 sections
- 21 C.F.R. § 516.111Scope of this subpart.
- 21 C.F.R. § 516.115Definitions.
- 21 C.F.R. § 516.117Submission of correspondence under this subpart.
- 21 C.F.R. § 516.119Permanent-resident U.S. agent for foreign requestors and holders.
- 21 C.F.R. § 516.121Meetings.
- 21 C.F.R. § 516.123Informal conferences regarding agency administrative actions.
- 21 C.F.R. § 516.125Investigational use of minor species new animal drugs to support indexing.
- 21 C.F.R. § 516.129Content and format of a request for determination of eligibility for indexing.
- 21 C.F.R. § 516.131Refuse to file a request for determination of eligibility for indexing.
- 21 C.F.R. § 516.133Denying a request for determination of eligibility for indexing.
- 21 C.F.R. § 516.135Granting a request for determination of eligibility for indexing.
- 21 C.F.R. § 516.137Notification of decision regarding eligibility for indexing.
- 21 C.F.R. § 516.141Qualified expert panels.
- 21 C.F.R. § 516.143Written report.
- 21 C.F.R. § 516.145Content and format of a request for addition to the index.
- 21 C.F.R. § 516.147Refuse to file a request for addition to the index.
- 21 C.F.R. § 516.149Denying a request for addition to the index.
- 21 C.F.R. § 516.151Granting a request for addition to the index.
- 21 C.F.R. § 516.153Notification of decision regarding index listing.
- 21 C.F.R. § 516.155Labeling of indexed drugs.
- 21 C.F.R. § 516.157Publication of the index and content of an index listing.
- 21 C.F.R. § 516.161Modifications to indexed drugs.
- 21 C.F.R. § 516.163Change in ownership of an index file.
- 21 C.F.R. § 516.165Records and reports.
- 21 C.F.R. § 516.167Removal from the index.
- 21 C.F.R. § 516.171Confidentiality of data and information in an index file.